Skip to content
Adverse-event reports (MAUDE)

Read this first: MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line shows reporting volume for the average device in the same FDA product code — a reporting baseline, not a risk measure.

No adverse-event reports are linked to this device.

Recall history
InitiatedRecall #ClassStatusReasonQuantityLink basis
2016-09-16Z-0055-2017Class ITerminatedVascular Solutions is recalling Twin-Pass dual access catheters because there is a potential for excess manufacturing material to remain at the tip of the catheter or within the distal portion of the rapid exchange lumen.Distribution: Worldwide Distribution: US (nationwide) including Puerto Rico and outside the US to include: Australia, Austria, Belgium, Brazil, Canada, Cyprus, Czech Republic, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom.11,670 units totalclearance family
Regulatory clearances

None linked.

Manufacturer compliance record
DateTypeOutcomeFacilityCitations
2025-10-10OAIOfficial action indicatedVascular Solutions, LLC (A Subsidiary of Teleflex)3
2021-11-16NAINo action indicatedVascular Solutions, LLC (A Subsidiary of Teleflex)0
2017-09-21NAINo action indicatedVascular Solutions, LLC (A Subsidiary of Teleflex)0
2014-07-15NAINo action indicatedVascular Solutions, LLC (A Subsidiary of Teleflex)0
2013-05-20NAINo action indicatedVascular Solutions, LLC (A Subsidiary of Teleflex)0
2013-04-08NAINo action indicatedVascular Solutions, LLC (A Subsidiary of Teleflex)0
2011-06-02VAIVoluntary action indicatedVascular Solutions, LLC (A Subsidiary of Teleflex)0
2010-05-10VAIVoluntary action indicatedVascular Solutions, LLC (A Subsidiary of Teleflex)3
Similar devices
Select up to two to place side-by-side with this device.